Fulgent Genetics, Inc.
FLGT
$14.63
$0.382.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.87% | 2.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.87% | 2.77% | |||
| Cost of Revenue | 4.52% | 2.51% | |||
| Gross Profit | -8.25% | 3.13% | |||
| SG&A Expenses | 44.95% | -9.57% | |||
| Depreciation & Amortization | 0.05% | 1.76% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.34% | -2.07% | |||
| Operating Income | -123.54% | 22.13% | |||
| Income Before Tax | -289.85% | 65.11% | |||
| Income Tax Expenses | -723.43% | 69.82% | |||
| Earnings from Continuing Operations | -246.47% | 64.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 6.42% | -27.09% | |||
| Net Income | -254.39% | 65.14% | |||
| EBIT | -123.54% | 22.13% | |||
| EBITDA | -202.86% | 31.83% | |||
| EPS Basic | -251.74% | 65.37% | |||
| Normalized Basic EPS | -274.09% | 36.02% | |||
| EPS Diluted | -252.58% | 65.37% | |||
| Normalized Diluted EPS | -274.09% | 36.02% | |||
| Average Basic Shares Outstanding | 0.75% | 0.67% | |||
| Average Diluted Shares Outstanding | 0.75% | 0.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||